What Is the Optimal NOAC for Korean NVAF Patients with Specific Considerations?
[Speaker] 심재민/고려의대
Changing Paradigm in Anti-thrombotic Treatment in Patients with High Risk CAD and/or PAD
[Speaker] 이종영/성균관의대